Zhong Huijuan

Zhong Huijuan

Zhong Huijuan (#150)

  • $ 18 B
  • Pharmaceuticals
  • China
  • F
  • 65 Years

About Me

Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs. Zhong's husband, Sun Piaoyang, is also a billionaire and leads Jiangsu Hengrui Pharmaceuticals, which is dual-listed in Shanghai and Hong Kong. Their daughter, Sun Yuan, is Hansoh's executive director. Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019. Hansoh has licensed products including weight-loss treatments to global pharmaceutical giants such as Merck in billion-dollar deals, as the firm expands internationally.
About Images

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Zhong Huijuan’s rise and global influence.

  • #16   China's 100 Richest (2025)
  • #3   World's Richest Self-Made Women (2025)
  • #257   Billionaires (2025)

Wealth Growth

Net Worth Growth Over Time

Tracking Zhong Huijuan’s net worth journey over the years, highlighting key growth phases and financial milestones.

Current Net Worth: $17.9B (February 5, 2026)